The FDA can’t get its story straight about reducing tobacco-related dangers
FDA Commissioner Robert Califf faced a tough situation recently. hearing Before members of the House Oversight Committee. From contraceptives and infant formula to COVID-19 treatments and regulatory actions by the Center for Tobacco Products, the session covered a wide range of FDA actions, or primarily the lack thereof. It may have been a long afternoon […]